The company started with a patent and a friends-and-family "and more friends" round in 2024. Now it's closed its biggest ...

Experts at the Comprehensive Stroke Center at Atrium Health Wake Forest Baptist are using an emerging therapy that involves a ...

In the following Q&A, IFA Magazine sits down with Zahid Bilgrami, CEO of Mortgage Brain, to discuss the launch of the company ...

Axoft, a neurotechnology company, today announced it has raised an oversubscribed $55 million Series A led by C.P. Group ...

Researchers from the Pacific Brain Health Center at Providence Saint John’s Health Center shared new findings showing that a structured lifestyle ...

Time is the primary evidence-backed intervention. Acute cannabis toxicity follows a self-limiting course, and the clinical ...

Medical Associates will hold the health talk from 6 to 7 p.m. April 28 at the Medical Associates West Campus Clinic, 1500 Associates Drive, according to a press release.

An analysis of hundreds of images from several studies shows how hallucinogenic drugs drive activity in various regions of the brain. By Andrew Jacobs As researchers have sought to demonstrate the ...

Scientists looked at a wide range of brain scans to determine how consciousness gets so trippy on mind-altering drugs. A new analysis broadens our understanding of psychedelics, such as the psilocybin ...

A decade ago in Davos, I spoke on a panel with Dr. Aki Hintsa, an orthopedic and trauma surgeon who was coaching Formula One drivers on brain health and performance. He was also working with Dr. Tommy ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Explore how Neuralink brain chips and ongoing Neuralink trials are advancing brain-computer interface technology, enabling thought control, digital communication, and groundbreaking medical ...